The capsule endoscopy systems offer a hands-free and highly accurate imaging modality for healthcare practitioners. A pill-sized capsule houses a miniature camera that captures the condition of esophageal tract lining. The technology was first introduced for commercial healthcare services in 2000. These capsule devices are now being used to help assess gastrointestinal issues related to cardiovascular devices. 


January 2, 2017 — The U.S. Food and Drug Administration (FDA) hopes to build clinical evidence through new registries for the utility of endovascular therapies to treat acute ischemic stroke. It plans to host a public workshop entitled “Coordinated Registry Network (CRN) for Devices Used for Acute Ischemic Stroke Intervention (DAISI).”

The workshop will be held Feb. 2, 2017, 8 a.m. to 5 p.m. at the Ruth L. Kirschstein Auditorium, Natcher Conference Center, Bldg. 45, National Institutes of Health Campus, 9000 Rockville Pike, Bethesda, Md. 20892.    

December 31, 2016 — NaviGate Cardiac Structures Inc. (NCSI) announced that a novel valved stent that can capture the enlarged annulus in patients suffering from functional tricuspid regurgitation (FTR) was implanted in a patient presenting with massive incompetence of the tricuspid valve.


Point of care testing devices are gaining widespread approval for prompt medical diagnoses, especially in cardiology and INR testing. 



The Cardioband System (Valtech) has recently been introduced as a potential option for transcatheter repair of the mitral valve among patients with functional mitral regurgitation (FMR). It has a CE mark in Europe, and a study to evaluate its safety and efficacy is planned in the United States.[1]  Use of the Cardioband is intended to reduce the size of the annulus by placing an annuloplasty ring around it. 


As wearable and implantable patient monitoring or therapy devices become more sophisticated with advanced wireless connectivity to extract patient information and change the device functionality, there are growing concerns these technologies will be targets of hackers. The U.S. Food and Drug Administration (FDA) believes this poses a threat to patient safety.

December 29, 2016 — The American College of Cardiology (ACC), along with several partnering organizations, recently released updated appropriate use criteria for performing coronary revascularization in patients with acute coronary syndromes.

Patients with acute coronary syndromes suffer from sudden, reduced blood flow to the heart, requiring quick diagnosis and care. Coronary revascularization is the restoration of this blood flow to the heart commonly by coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI).

Subscribe Now